Clinical Trial Update: Study to Evaluate the Safety and Efficacy of ASC41 in Overweight and Obese Subjects [Phase 1]

View source ↗

Summary

Completed Phase 1 trial evaluating the safety and initial efficacy of ASC41 in overweight and obese subjects, including participants with NAFLD and hyperlipidem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia
• Nonalcoholic Fatty Liver Disease
• Obesity

Drugs mentioned

• ASC41

Snippet

Sponsor: Gannex Pharma Co., Ltd. | Conditions: Overweight and Obesity, NAFLD | Phase 1 | Status: COMPLETED